日间机器人肝切除术的引入:一家三级肝胆胰中心的病例系列
该单术者病例系列纳入2022年9月至2023年11月一家三级肝胆胰中心20例行机器人日间小范围肝切除的患者,平均手术时间86.6±30.9分钟,13例(65%)在术后24小时内出院,超过24小时住院的主要原因镇痛不足,无Clavien-Dindo III级及以上并发症、无30天再入院和90天死亡。作者认为机器人日间肝切除安全可行,但需建立完善的随访路径。
要点
- 20例机器人日间小范围肝切除中13例(65%)在24小时内出院。
- 超过24小时住院的主要原因是镇痛不足。
- 无Clavien-Dindo III级及以上并发症、无30天再入院和90天死亡。
核心结论
- 该病例系列表明机器人日间肝切除安全可行。
- 必须建立完善的随访路径以安全实施该方法、监测并发症并及时干预。
研究设计与样本
- 单术者病例系列,于2022年9月至2023年11月在一家三级肝胆胰中心实施。
- 共纳入20例患者。
- 纳入标准为非解剖性楔形切除、少于2个解剖性肝段切除、左肝外侧叶切除和微创手术。
主要发现
- 平均手术时间为86.6±30.9分钟,平均操作台时间为58.6±24.5分钟。
- 13例患者(65%)在术后24小时内出院。
- 超过24小时住院的主要原因是镇痛不足。
- 无Clavien-Dindo III级及以上并发症、无30天再入院和90天死亡。
关键数值与推荐
- 纳入标准为非解剖性楔形切除、少于2个解剖性肝段切除、左肝外侧叶切除和微创手术。
- 患者计划在入院24小时内出院。
临床怎么用
- 作者认为机器人日间肝切除安全可行,但必须建立完善的随访路径以监测并发症并及时干预。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Liver surgery is associated with a significant hospital stay regardless the type of liver resection. A large incision is essential for open liver surgery which is a major factor in the course of the patient's recovery. For patients with small parenchyma liver lesions requiring surgical resection, robotic surgery potentially offers the opportunity to transform the patient's post-operative course. A day-case robotic liver resection pathway was formulated and implemented at our institution when patients were planned for discharge within 24 h of admission for liver surgery. METHODS: Single surgeon case series of cases performed at a tertiary hepatobiliary and pancreatic centre between September 2022 and November 2023. The inclusion criteria were non-anatomical wedge resections, < 2 anatomical segmental resections, left lateral hepatectomy and minimally invasive surgery. RESULTS: This is the first series of robotic day-case minor liver resection in the United Kingdom. 20 patients were included in this case series. The mean operative time was 86.6 ± 30.9 min and mean console time was 58.6 ± 24.5 min. Thirteen patients (65%) were discharged within 24 h of surgery. The main cause of hospitalisation beyond 24 h was inadequate pain relief. There were no Clavien-Dindo grade III or above complications, no 30-day readmission and 90-day mortalities. CONCLUSION: This case series demonstrates that robotic day-case liver resection is safe and feasible. Robust follow-up pathways must be in place to allow for the safe implementation of this approach, to monitor for any complications and to allow intervention as required in a timely manner.
引用
- Yeung KTD, Vellaisamy R, Hussain A, et al. Introduction of day-case robotic liver surgery: a case series from a tertiary hepatobiliary and pancreatic centre. Surg Endosc. 2024. PMID: 38874609. doi:10.1007/s00464-024-10913-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。